Series 3000 High Pressure Reducing Regulator | Equilibar

Series 3000 High Pressure Reducing Regulator

Port Sizes:
1/4"
Typical Pressure Ranges:
0 - 250 psi0 - 500 psi0 - 1000 psi0 - 1500 psi
0 - 2500 psi0 - 4000 psi0 - 6000 psi0 - 10000 psi
Body Material (Standard):
360 Brass or 316 Stainless Steel
Key Applications:

• Pilot operating Equilibar Back Pressure Regulators
• Research labs
• Manufacturing process
Petrochemical plants
Aircraft support system

Product Description
high pressure regulator

Series 3000 High Pressure Reducing Regulator

The high pressure 3000 Series pressure reducing regulators are single stage, piston sensed, variable delivery, pressure reducing
regulators, designed for inlet and outlet pressures up to 10,000 psig (689.5 bar(g)) and Cv 0.06.

3000 Series regulators are used to regulate a broad range of non-corrosive and corrosive media (based on materials of
construction). They are designed for increased serviceability and reliable operation with the integral 15 micron stainless steel
valve cartridge filter.

The Series 3000 is a self-relieving regulator that should be used only with compressed gases (not liquids). The Series
3000 is most often used to provide the pilot pressure signal to an Equilibar back pressure regulator, but can be used in any
application where relatively small volumes of compressed gas pressure must be controlled.

Videos
high pressure regulator

Series 3000 High Pressure Reducing Regulator

Downloads
Applications
high pressure regulator

Series 3000 High Pressure Reducing Regulator

• Pilot operating Equilibar Back Pressure Regulators
• Research labs
• Manufacturing process
Petrochemical plants
Aircraft support system

Additional Specs
high pressure regulator

Series 3000 High Pressure Reducing Regulator

Weight:

5.0 lbs (2.27 kg)

Dimensions:

 

 

 

 

Fitting/Threads:

Standard: 1/4”  female NPT

How It Works
high pressure regulator

Series 3000 High Pressure Reducing Regulator

Related Products

Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More